DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Camlin Fine Sciences Limited — Board Meeting Intimation

NSE 4 hrs ago·4 Aug 2026, 9:41 am

Camlin Fine Sciences

Camlin Fine Sciences Limited has announced that its board will meet on August 11, 2026, to review and approve the company's unaudited financial results for the quarter ending June 2026.

This scheduled board meeting is a routine corporate event that typically signals the release of quarterly earnings. For investors, the key focus will be on the company's financial performance, including revenue growth and profit margins, which are critical indicators of its current operational health.

Investors should watch for the release of the financial statements and any management commentary regarding the quarter's performance. This data will provide clarity on the company's trajectory and help assess its future growth prospects.